Dye imaging test during breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial tests a special dye technique used during breast cancer surgery. The dye helps doctors see if all cancer cells have been removed, which may lower the chance of needing a second surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are scheduled for surgery to remove a breast tumor.
- Your tumor is a single lump, 5 cm or smaller (if you haven't had chemo before surgery).
- You are not allergic to two specific dyes (methylene blue or sodium fluorescein).
- You are not pregnant or breastfeeding, and you can complete follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special dye called ICG that makes cancer glow under a special camera during breast cancer surgery. Doctors want to find the best time to give the dye so they can see the cancer clearly and remove all of it in one operation.
This study tests a special dye that helps surgeons see breast cancer tissue and nearby lymph nodes more clearly during surgery. The goal is to make sure all cancer is removed while sparing healthy tissue.
This trial tests a new method to find and remove lymph nodes in the armpit after chemotherapy shrinks breast cancer. It uses a safe blue dye to help surgeons identify which nodes to remove, potentially reducing complications while ensuring thorough treatment.
This study tests a new injectable dye (NC527-X) that helps surgeons see tumors better during surgery. The dye glows under special light, making it easier to find and remove cancer tissue completely.
This trial tests whether a special MRI and an injected light-activated dye (pHLIP® ICG) can help doctors see and target breast cancer during surgery. You may be offered this approach around the time of breast-conserving surgery, to improve how well the tumor area is identified.
This trial tests a new imaging system that helps surgeons see if cancer cells remain after breast-conserving surgery. It may reduce the need for a second surgery by giving real-time feedback on the removed tissue.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.